NEW YORK (GenomeWeb) – Meridian Bioscience today reported flat fiscal fourth quarter revenues and a 1 percent increase in fiscal year 2016 revenues.

The results were consistent with preliminary earnings announced last month that sent the firm's stock tumbling.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.